Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,774,201
-$3,620,112 QoQ
Shares Held
337,697
0.0% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
2.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026venBio Partners LLC holds $280,553,199 across 6 Biotechnology names. LYEL ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,639,304 | $131,060,338 | |
| 2 | ALMS |
Alumis Inc.
|
4,528,408 | $99,760,828 | |
| 3 | ALXO |
Alx Oncology Holdings Inc
|
12,884,638 | $25,833,699 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
489,194 | $13,702,323 | |
| 5 | LYEL |
Lyell Immunopharma, Inc.
This page
|
337,697 | $6,774,201 | |
| 6 | ARTV |
Artiva Biotherapeutics, Inc.
|
531,337 | $3,421,810 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,774,201 | 337,697 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,394,313 | 337,697 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,689,298 | 473,479 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,185,554 | 473,479 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||